(34.236.191.104)
Users online: 3086    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2018, Volume : 11, Issue : 7
First page : ( 3234) Last page : ( 3236)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2018.00594.2

Management of Osteoradionecrosis of the Mandible

Sathiyawathie R. Sarah1,*, Ganapathy Dhanraj2

1Tutor, Department of Conservative and Endodontics, Saveetha Dental College, Saveetha University, Chennai, India

2Professor and Head of Department, Department of Prosthodontics, Saveetha Dental College, Saveetha University, Chennai, India

*Corresponding Author E-mail: dr.sarahrobin@gmail.com

Online published on 31 October, 2018.

Abstract

Osteoradionecrosis has been a serious and not infrequent complication that can affect both adults and children following radiation therapy. The incidence of osteoradionecrosis varies widely in the literature ranging from 1% to 37%. Over the last few decades, several therapeutic options including supportive measures, ultrasound therapy, corticosteroids, hyperbaric oxygen, surgical resection with reconstruction and most recently drugs capable of reversing the fibroatrophic process were considered in the treatment of osteroradionecrosis of the mandible.

Top

Keywords

Mandible, osteoradionecrosis, hyperaemia, endarteritis, management.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
520,673,659 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.